Medical devices, healthcare technology and the business of care
PMA approval · P010031

CONCERTO/INSYNC SENTRY/INSYNC MAXIMO IMPLANTABLE CARDIOVASCULAR DEFIBRILLATORS WITH CARDIAC RESYNCHICNIZATION

Medtronic Cardiac Rhythm Disease Management · Decision date Jun 26, 2002

FDA DECISIONP010031

What did the FDA approve?

FDA records P010031 as an original PMA application. The recorded decision is approval, dated Jun 26, 2002.

FDA approval order statement

APPROVAL FOR THE INSYNC ICD MODEL 7272 DUAL CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATOR WITH CARDIAC RESYNCHRONIZATION THERAPY AND THE MODEL 9969 APPLICATION SOFTWARE. THE INSYNC ICD MODEL 7272 IS INDICATED FOR VENTRICULAR ANTITACHYCARDIA PACING AND VENTRICULAR DEFIBRILLATION FOR AUTOMATED TREATMENT OF LIFE THREATENING VENTRICULAR ARRHYTHMIAS. THE SYSTEM IS ALSO INDICATED FOR THE REDUCTION OF THE SYMPTOMS OF MODERATE TO SEVERE HEART FAILURE (NYHA FUNCTIONAL CLASS III OR IV) IN THOSE PATIENTS WHO REMAIN SYMPTOMATIC DESPITE STABLE, OPTIMAL MEDICAL THERAPY (AS DEFINED IN THE CLINICAL TRIALS SECTION), AND HAVE A LEFT VENTRICULAR EJECTION FRACTION LESS THAN OR EQUAL TO 35% AND A QRS DURATION GREATER THAN OR EQUAL TO 130 MS.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jun 26, 2002

FDA source record

Regulatory record facts

Identifier
P010031
Regulatory pathway
Premarket approval application
Product code
NIK
Decision code
APPR
Decision date
Jun 26, 2002
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D).

Product code
NIK
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P010031 received

    Application receipt date recorded by FDA.

  2. P010031 · FDA decision

    APPR

  3. P010031/S932 · Related supplement

    Cobalt MRI CRT-D, Cobalt XT MRI CRT-D, Crome MRI CRT-D

  4. P010031/S933 · Related supplement

    Cobalt MRI CRT-D (DTPB2Dl, DTPB2D4, DTPB2Ql, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2Dl, DTPA2D4, DTPA2Ql, DTPA2QQ); Crome M

  5. P010031/S934 · Related supplement

    Cobalt MRI CRT-D, Cobalt XT MRI CRT-D, Crome MRI CRT-D

  6. P010031/S931 · Related supplement

    Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Crome M

Timeline entries are records held by MedtechLedger for P010031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010031

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records